⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GRAL News
GRAIL, Inc. Common Stock
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
prnewswire.com
GRAL
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
globenewswire.com
GRAL
Mercy Joins Clinical Study for Blood Test That Screens for Multiple Types of Cancers
prnewswire.com
GRAL
MCESC Deepens Countywide Efforts to Re-Engage Students and Strengthen Pathways to Success
prnewswire.com
GRAL
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference
prnewswire.com
GRAL
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
prnewswire.com
GRAL
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference
prnewswire.com
GRAL
GRAIL Reports Third Quarter 2025 Financial Results
prnewswire.com
GRAL
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference
prnewswire.com
GRAL
GRAIL to Announce Third Quarter 2025 Financial Results
prnewswire.com
GRAL